A novel view of opiate tolerance

Advances in Neuroimmunology
1996.0

Abstract

Opiate substances occur as natural compounds in various invertebrate and vertebrate neural tissues. Recently we have discovered a novel opiate alkaloid-selective and opioid peptide-insensitive receptor, designated mu 3, that provides further evidence of the existence of separate morphine processes. Interestingly morphine biosynthesis appears to be linked to the dopamine pathway. Based on studies documenting the presence of morphine after stress, e.g., trauma, it is noted that this signal substance emerges after a timely delay. From this we speculate that this molecule can serve a specific effect to downregulate physiological processes after stress. We conclude that tolerance represents a natural process that terminates its action. In this regard a morphine hypothesis may be essential to a complete picture of motive circuitry. A speculative view of the psychiatric implications in schizophrenia, depression, and autism are presented with this in mind.

Knowledge Graph

Similar Paper

A novel view of opiate tolerance
Advances in Neuroimmunology 1996.0
The presence of the μ3 opiate receptor in invertebrate neural tissues
Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 1996.0
Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: Implications for cancer biology
Seminars in Cancer Biology 2008.0
The Opioid μ Agonist/δ Antagonist DIPP-NH<sub>2</sub>[Ψ] Produces a Potent Analgesic Effect, No Physical Dependence, and Less Tolerance than Morphine in Rats
Journal of Medicinal Chemistry 1999.0
Synthesis, Conformation, and Biological Characterization of a Sugar Derivative of Morphine that is a Potent, Long-Lasting, and Nontolerant Antinociceptive
Journal of Medicinal Chemistry 2009.0
Presence of morphine and morphine-6-glucuronide in the marine mollusk Mytilus edulis ganglia determined by GC/MS and Q–TOF–MS
Molecular Brain Research 2001.0
Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity
Bioorganic &amp; Medicinal Chemistry 2014.0
Morphiceptin Analogues Containing a Dipeptide Mimetic Structure:  An Investigation on the Bioactive Topology at the μ-Receptor
Journal of Medicinal Chemistry 2005.0
Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists
Scientific Reports 2020.0
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine’s Biological Activity
Journal of Medicinal Chemistry 2020.0